Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Randomized, Single-Dose, 2-way Crossover Bioequivalence Study of Amlodipine and Norvasc Under Fasting Condition Sand Under Non-fasting(FED) Conditions in Chinese Healthy Volunteers

NCT02974439 is registered in ClinicalTrials.gov with Shanghai Haini Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT02974439
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02974439 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Randomized, Single-Dose, 2-way Crossover Bioequivalence Study of Amlodipine and Norvasc Under Fasting Condition Sand Under Non-fasting(FED) Conditions in Chinese Healthy Volunteers
Lead sponsor
Shanghai Haini Pharmaceutical Co., Ltd.
Phase
Phase 1
Overall status
Completed
Start date
December 23, 2016
Completion date
March 21, 2017
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bioequivalence